Navigation Links
TREVENTIS Corporation Founder Wins Prestigious Discovery Award
Date:1/11/2011

PHILADELPHIA and Nova Scotia, CANADA, Jan. 11, 2011 /PRNewswire/ -- TREVENTIS Corporation founder, Christopher Barden, Ph.D., was awarded "Emerging Professional Award" for his work in computer-aided drug design.  Dr. Barden received the Award at the 8th annual Discovery Awards dinner sponsored by Nova Scotia's Discovery Centre.  His work has provided TREVENTIS with a proprietary drug discovery system called the Common Conformational Motif (CCM).  

In addition, Company founder Sultan Darvesh, M.D., Ph.D., was one of only three finalists in the category of "Professional of Distinction" for his work and recognized expertise in the field of butyrylcholinesterase (BuChE) as a diagnostic and therapeutic target in diseases of the brain.  Dr. Darvesh heads the Company's efforts in developing a diagnostic test for Alzheimer's disease.  

Finalists and award winners are recognized by the Discovery Centre as the top science practitioners in Nova Scotia.  Three finalists are selected among all of Nova Scotia's scientific professionals in both the regular Professional and early-career Emerging categories.  The Discovery Awards "recognize the talented individuals...whose exemplary work in science and technology inspire us all," according to its web site (www.discoverycentre.ns.ca).  Past recipients of the Discovery Award include TREVENTIS founder Donald Weaver, M.D., Ph.D., a neurologist and recognized expert in Alzheimer's disease.

"We are delighted to have the scientific foundation of the Company validated by this prestigious award," said Bill McIntosh, CEO of TREVENTIS Corporation.  "That they were nominated for these awards is clear recognition of the significant work they are doing for the Company and for science."

Dr. Barden is part of a team of TREVENTIS chemists and biologists who have discovered and synthesized multiple classes of therapeutic compounds that block the aggregation of misfolding proteins.  Misfolding proteins have been implicated in numerous CNS diseases including Parkinson's disease and Alzheimer's disease, the Company's current focus.  

About TREVENTIS Corporation

TREVENTIS Corporation, headquartered in Southeastern Pennsylvania, has research operations in Halifax, Nova Scotia, Canada.  The company is focused on the discovery and early stage development of disease-modifying, small molecule drugs for Alzheimer's and other protein misfolding diseases such as Parkinson's and Huntington's disease.  In addition to its therapeutics programs, TREVENTIS has a novel approach to the development of diagnostics for early diagnosis as well as monitoring treatment effects in Alzheimer's disease, MS and primary brain tumors.For more information contact:

L. William McIntosh, CEOTREVENTIS Corporationwww.TREVENTIS. commcamci@msn.com and wmcintosh@treventis.com610-488-6081  
'/>"/>

SOURCE TREVENTIS Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Saints Medical Center and ZOLL Medical Corporation Enter Collaborative Agreement
2. Luminex Corporation to Present at JP Morgan Healthcare Conference
3. SRI International Completes Integration of Sarnoff Corporation
4. Heska Corporation Announces Stockholder Approval of Reverse Split
5. Pfizer Animal Health to Acquire Synbiotics Corporation, Entering Diagnostics Sector
6. Webcast Alert: Heska Corporations Special Meeting of Stockholders Webcast
7. LodgeNet Healthcare, MDM Healthcare and Child Health Corporation of America Reach Agreement
8. VIDEO from Siemens Corporation Available on thenewsmarket.com: Amazing Medical Images: Diagnosing in the Digital Age
9. Heska Corporation Awards $25,000 Grand Prize to Pets Forever
10. Unilife Corporation Moves into New State-of-the-Art Manufacturing Facility and Global Headquarters
11. Oxford Finance Corporation Hires Debbie Baker to Support Life Science Business Development in Western North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Texas , May 25, 2016 ... the issuance to it by the US Patent ... The company,s technology includes proprietary processes for electronic ... for health and wellness programs, HIPAA compliance and ... "Our technology ...
(Date:5/24/2016)... Cirujanos holandeses han puesto en marcha una ... compartir sus mejores prácticas por el mundo y tratar ... Europa, África, Asia y Estados ... combina la transmisión en vivo con mensajería instantánea y ... "Imagine un médico de Medicines sans Frontieres ...
(Date:5/24/2016)...  NxStage Medical, Inc. (Nasdaq: NXTM ), ... care, today announced that Jeffrey H. Burbank , ... schedule of investor conferences. Where applicable, a webcast of ... .   ... Friday, June 10, 2016 1:30 p.m. ET ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... ... is happy to announce the launch of its brand equity product, Brandvantage. ... to reflect the dynamic landscape of modern consumer decision-making. The proprietary framework ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Development Team of ... for FCPX. , "This new layered style transition tool will keep a consistent ... - CEO of Pixel Film Studios. , TranSweep is an all new layered ...
(Date:5/26/2016)... Beach, Florida (PRWEB) , ... May 26, 2016 , ... ... connected to the mainland by a single drawbridge, citizens formed an organization, Madeira Beach ... already congested traffic and change the small town center to a high rise urban ...
(Date:5/26/2016)... ... May 26, 2016 , ... According to the Webster’s dictionary, a ... with chemical-laden beauty products, one company is going against the norm with a line ... The rising star in the green space is proud to announce its latest retail ...
(Date:5/26/2016)... California (PRWEB) , ... May 26, 2016 , ... ... Barbara this Memorial Day weekend to host their second pop-up shop for three ... Diego fashion forward brand to the Santa Barbara community, a community full of ...
Breaking Medicine News(10 mins):